Role of streptolysin O in a mouse model of invasive group A streptococcal disease

Infection and Immunity

Volumn 68, Issue 11, 2000, Pages 6384-6390

  Limbago, B ^a   Penumalli, V ^a   Weinrick, B ^a   Scott, J R ^a  

^a EMORY UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

STREPTOLYSIN O; VIRULENCE FACTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BACTERIAL VIRULENCE; CONTROLLED STUDY; CYTOLYSIS; EUKARYOTIC CELL; MORTALITY; MOUSE; NONHUMAN; PATHOGENICITY; PRIORITY JOURNAL; STREPTOCOCCUS GROUP A; STREPTOCOCCUS INFECTION; STREPTOCOCCUS PYOGENES;

ANIMAL; DISEASE MODELS, ANIMAL; FEMALE; HEMOLYSIS; MICE; SKIN DISEASES, BACTERIAL; STREPTOCOCCUS PYOGENES; STREPTOLYSINS; SUPPORT, U.S. GOV'T, P.H.S.; VIRULENCE;

EID: 0033789226     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/IAI.68.11.6384-6390.2000     Document Type: Article

References (43)

1. Streptococcal toxins (streptolysin O, streptolysin S, erythrogenic toxin)
2. The family of the antigenically-related cholesterol-binding ('sulphydryl-activated') cytolytic toxins
3. Molecular analysis of the role of the group A streptococcal cysteine protease, hyaluronic acid capsule, and M protein in a murine model of human invasive soft-tissue infection
4. Lesions in the mouse produced by streptolysins O and S
5. Comparative virulence of Streptococcus pneumoniae strains with insertion-duplication, point, and deletion mutations in the pneumolysin gene
6. Reduced virulence of group A streptococcal Tn916 mutants that do not produce streptolysin S
7. Streptococcal infections of skin and soft tissues
8. Isolation of a prokaryotic plasmin receptor: Relationships to a plasminogen activator produced by the same micro-organism
9. Genetic and phenotypic diversity among isolates of Streptococcus pyogenes from invasive infections
10. Listeriolysin O is essential for virulence of Listeria monocytogenes: Direct evidence obtained by gene complementation
11. Mechanisms of cell and tissue injury induced by group A streptococci: Relation to poststreptococcal sequelae
12. Can we learn from the pathogenetic strategies of group A hemolytic streptococci how tissues are injured and organs fail in post-infectious and inflammatory sequelae?
13. Streptococcal toxic shock syndrome: Synthesis of tumor necrosis factor and interleukin-1 by monocytes stimulated with pyrogenic exotoxin A and streptolysin O
14. Streptolysin O
15. Motion picture study of the toxic action of streptolysins on leukocytes
16. Rapid selection of complement-inhibiting protein variants in group A streptococcus epidemic waves
17. The comparative resistance of rabbits, guinea pigs and mice to the lethal actions of streptolysin O and saponin
18. Role of putative virulence factors of Streptococcus pyogenes in mouse models of long-term throat colonization and pneumonia
19. Epidemiologic analysis of group A streptococcal serotypes associated with severe systemic infections, rheumatic fever, or uncomplicated pharyngitis
20. Group A streptococcal serotypes isolated from patients and sibling contacts during the resurgence of rheumatic fever in the United States in the mid-1980s
21. Current knowledge of type-specific M antigens of group A streptococci
22. Biochemical and ultrastructural study of the disruption of blood platelets by streptolysin O
23. Extracellular cysteine protease produced by Streptococcus pyogenes participates in the pathogenesis of invasive skin infection and dissemination in mice
24. Molecular epidemiology of group A streptococcus M type 1 infections
25. Serotype, biotype, pyrogenic exotoxin, streptolysin O and exoenzyme patterns of invasive Streptococcus pyogenes isolates from patients with toxin shock syndrome, bacteremia and other severe infections
26. Molecular comparison of group A streptococci of T1M1 serotype from invasive and noninvasive infections in Finland
27. A major surface protein on group A streptococci is a glyceraldehyde-3-phosphate-dehydrogenase with multiple binding activity
28. Effects of intraventricular injections of streptolysin O in unanesthetized carts
29. Streptolysin O and adherence synergistically modulate proinflammatory responses of keratinocytes to group A streptococci
30. Severe invasive group A streptococcal disease: Clinical description and mechanisms of pathogenesis
31. Hyaluronic acid capsule and the role of streptococcal entry into keratinocytes in invasive skin infection
32. Changing epidemiology of group A streptococcal infection in the USA
33. The M protein of group A streptococcus: Evolution and regulation
34. Comparison of pathogenic factors expressed by group A streptococci isolated from patients with streptococcal toxic shock syndrome and scarlet fever
35. Invasive group A streptococcus infections
36. Severe group A streptococcal infections associated with a toxic shock-like syndrome and scarlet fever toxin A
37. Hypervariability generated by natural selection in an extracellular complement-inhibiting protein of serotype M1 strains of group A streptococcus
38. Association of phenotypic and genotypic characteristics of invasive Streptococcus pyogenes isolates with clinical components of streptococcal toxic shock syndrome
39. Lethal toxins of hemolytic streptococci and their antibodies
40. Differences between streptococcal infections of the throat and of the skin
41. Invasive group A streptococcal disease in metropolitan Atlanta: A population-based assessment